Cargando…

Immunologic memory to SARS-CoV-2 in convalescent COVID-19 patients at 1 year postinfection

BACKGROUND: Understanding the complexities of immune memory to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is key to gain insights into the durability of protective immunity against reinfection. OBJECTIVE: We sought to evaluate the immune memory to SARS-CoV-2 in convalescent patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Hou, Hongyan, Zhang, Yandi, Tang, Guoxing, Luo, Ying, Liu, Wei, Cheng, Chang, Jiang, Yuhuan, Xiong, Zhigang, Wu, Shiji, Sun, Ziyong, Xu, Shabei, Fan, Xionglin, Wang, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8440318/
https://www.ncbi.nlm.nih.gov/pubmed/34536418
http://dx.doi.org/10.1016/j.jaci.2021.09.008
_version_ 1783752685844955136
author Hou, Hongyan
Zhang, Yandi
Tang, Guoxing
Luo, Ying
Liu, Wei
Cheng, Chang
Jiang, Yuhuan
Xiong, Zhigang
Wu, Shiji
Sun, Ziyong
Xu, Shabei
Fan, Xionglin
Wang, Feng
author_facet Hou, Hongyan
Zhang, Yandi
Tang, Guoxing
Luo, Ying
Liu, Wei
Cheng, Chang
Jiang, Yuhuan
Xiong, Zhigang
Wu, Shiji
Sun, Ziyong
Xu, Shabei
Fan, Xionglin
Wang, Feng
author_sort Hou, Hongyan
collection PubMed
description BACKGROUND: Understanding the complexities of immune memory to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is key to gain insights into the durability of protective immunity against reinfection. OBJECTIVE: We sought to evaluate the immune memory to SARS-CoV-2 in convalescent patients with longer follow-up time. METHODS: SARS-CoV-2–specific humoral and cellular responses were assessed in convalescent patients with coronavirus disease 2019 (COVID-19) at 1 year postinfection. RESULTS: A total of 78 convalescent patients with COVID-19 (26 moderate, 43 severe, and 9 critical) were recruited after 1 year of recovery. The positive rates of both anti–receptor-binding domain and antinucleocapsid antibodies were 100%, whereas we did not observe a statistical difference in antibody levels among different severity groups. Accordingly, the prevalence of neutralizing antibodies (nAbs) reached 93.59% in convalescent patients. Although nAb titers displayed an increasing trend in convalescent patients with increased severity, the difference failed to achieve statistical significance. Notably, there was a significant correlation between nAb titers and anti–receptor-binding domain levels. Interestingly, SARS-CoV-2–specific T cells could be robustly maintained in convalescent patients, and their number was positively correlated with both nAb titers and anti–receptor-binding domain levels. Amplified SARS-CoV-2–specific CD4(+) T cells mainly produced a single cytokine, accompanying with increased expression of exhaustion markers including PD-1, Tim-3, TIGIT, CTLA-4, and CD39, while the proportion of multifunctional cells was low. CONCLUSIONS: Robust SARS-CoV-2–specific humoral and cellular responses are maintained in convalescent patients with COVID-19 at 1 year postinfection. However, the dysfunction of SARS-CoV-2–specific CD4(+) T cells supports the notion that vaccination is needed in convalescent patients for preventing reinfection.
format Online
Article
Text
id pubmed-8440318
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.
record_format MEDLINE/PubMed
spelling pubmed-84403182021-09-15 Immunologic memory to SARS-CoV-2 in convalescent COVID-19 patients at 1 year postinfection Hou, Hongyan Zhang, Yandi Tang, Guoxing Luo, Ying Liu, Wei Cheng, Chang Jiang, Yuhuan Xiong, Zhigang Wu, Shiji Sun, Ziyong Xu, Shabei Fan, Xionglin Wang, Feng J Allergy Clin Immunol Covid-19 BACKGROUND: Understanding the complexities of immune memory to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is key to gain insights into the durability of protective immunity against reinfection. OBJECTIVE: We sought to evaluate the immune memory to SARS-CoV-2 in convalescent patients with longer follow-up time. METHODS: SARS-CoV-2–specific humoral and cellular responses were assessed in convalescent patients with coronavirus disease 2019 (COVID-19) at 1 year postinfection. RESULTS: A total of 78 convalescent patients with COVID-19 (26 moderate, 43 severe, and 9 critical) were recruited after 1 year of recovery. The positive rates of both anti–receptor-binding domain and antinucleocapsid antibodies were 100%, whereas we did not observe a statistical difference in antibody levels among different severity groups. Accordingly, the prevalence of neutralizing antibodies (nAbs) reached 93.59% in convalescent patients. Although nAb titers displayed an increasing trend in convalescent patients with increased severity, the difference failed to achieve statistical significance. Notably, there was a significant correlation between nAb titers and anti–receptor-binding domain levels. Interestingly, SARS-CoV-2–specific T cells could be robustly maintained in convalescent patients, and their number was positively correlated with both nAb titers and anti–receptor-binding domain levels. Amplified SARS-CoV-2–specific CD4(+) T cells mainly produced a single cytokine, accompanying with increased expression of exhaustion markers including PD-1, Tim-3, TIGIT, CTLA-4, and CD39, while the proportion of multifunctional cells was low. CONCLUSIONS: Robust SARS-CoV-2–specific humoral and cellular responses are maintained in convalescent patients with COVID-19 at 1 year postinfection. However, the dysfunction of SARS-CoV-2–specific CD4(+) T cells supports the notion that vaccination is needed in convalescent patients for preventing reinfection. The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology. 2021-12 2021-09-15 /pmc/articles/PMC8440318/ /pubmed/34536418 http://dx.doi.org/10.1016/j.jaci.2021.09.008 Text en © 2021 The Authors Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Covid-19
Hou, Hongyan
Zhang, Yandi
Tang, Guoxing
Luo, Ying
Liu, Wei
Cheng, Chang
Jiang, Yuhuan
Xiong, Zhigang
Wu, Shiji
Sun, Ziyong
Xu, Shabei
Fan, Xionglin
Wang, Feng
Immunologic memory to SARS-CoV-2 in convalescent COVID-19 patients at 1 year postinfection
title Immunologic memory to SARS-CoV-2 in convalescent COVID-19 patients at 1 year postinfection
title_full Immunologic memory to SARS-CoV-2 in convalescent COVID-19 patients at 1 year postinfection
title_fullStr Immunologic memory to SARS-CoV-2 in convalescent COVID-19 patients at 1 year postinfection
title_full_unstemmed Immunologic memory to SARS-CoV-2 in convalescent COVID-19 patients at 1 year postinfection
title_short Immunologic memory to SARS-CoV-2 in convalescent COVID-19 patients at 1 year postinfection
title_sort immunologic memory to sars-cov-2 in convalescent covid-19 patients at 1 year postinfection
topic Covid-19
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8440318/
https://www.ncbi.nlm.nih.gov/pubmed/34536418
http://dx.doi.org/10.1016/j.jaci.2021.09.008
work_keys_str_mv AT houhongyan immunologicmemorytosarscov2inconvalescentcovid19patientsat1yearpostinfection
AT zhangyandi immunologicmemorytosarscov2inconvalescentcovid19patientsat1yearpostinfection
AT tangguoxing immunologicmemorytosarscov2inconvalescentcovid19patientsat1yearpostinfection
AT luoying immunologicmemorytosarscov2inconvalescentcovid19patientsat1yearpostinfection
AT liuwei immunologicmemorytosarscov2inconvalescentcovid19patientsat1yearpostinfection
AT chengchang immunologicmemorytosarscov2inconvalescentcovid19patientsat1yearpostinfection
AT jiangyuhuan immunologicmemorytosarscov2inconvalescentcovid19patientsat1yearpostinfection
AT xiongzhigang immunologicmemorytosarscov2inconvalescentcovid19patientsat1yearpostinfection
AT wushiji immunologicmemorytosarscov2inconvalescentcovid19patientsat1yearpostinfection
AT sunziyong immunologicmemorytosarscov2inconvalescentcovid19patientsat1yearpostinfection
AT xushabei immunologicmemorytosarscov2inconvalescentcovid19patientsat1yearpostinfection
AT fanxionglin immunologicmemorytosarscov2inconvalescentcovid19patientsat1yearpostinfection
AT wangfeng immunologicmemorytosarscov2inconvalescentcovid19patientsat1yearpostinfection